Replies to post #94334 on Ayala Pharmaceuticals Inc (fka ADXS)

[DewDiligence]

Re: ADXS-NEO

The (newly disclosed) melanoma and bladder indications come into play only when a checkpoint inhibitor gets added in Part B of the ADXS-NEO trial—see slide #22.

As to your observation of oddity, see #msg-146129931.